Scott John K Jr.

CIK 00017537631 companyGREENWOOD VILLAGE, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001753763

Recent Transactions

35 trades

Other
NAVIDEA BIOPHARMACEUTICALS, INC.
Series I Convertible Preferred Stock
2023-11-27$1000.00/sh−2,400→ 0 total
Other
NAVIDEA BIOPHARMACEUTICALS, INC.
Series J Convertible Preffered Stock
2023-11-27$100.00/sh+64,289→ 64,289 total
Other
NAVIDEA BIOPHARMACEUTICALS, INC.
Series G Redeemable Preferred Stock
2023-11-27−2,270→ 0 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2023-06-29$0.09/sh+12,200,000→ 31,755,832 total
Conversion
NAVIDEA BIOPHARMACEUTICALS, INC.
Series J Convertible Preferred Stock
2023-06-05$100.00/sh−11,969→ 0 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2023-06-05+11,508,672→ 19,555,832 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Series J Convertible Preferred Stock
2023-06-01$100.00/sh+11,969→ 11,969 total
Other
NAVIDEA BIOPHARMACEUTICALS, INC.
Series G Redeemable Preferred Stock
2023-06-01−990→ 2,270 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-11-30+1,250→ 8,109,645 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-10-31+2,500→ 8,108,395 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-09-30+2,500→ 8,105,895 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-08-31+2,500→ 8,103,395 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Warrant to Purchase Common Stock
2022-08-30+2,400→ 2,400 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Series I Convertible Preferred Stock
2022-08-30+2,400→ 2,400 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Series F Redeemable Convertible Preferred Stock
2022-08-30$1379.31/sh−1,740→ 0 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-07-31+2,500→ 8,100,895 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-06-30+2,500→ 8,098,395 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-05-31+2,500→ 8,095,895 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-04-30+2,500→ 8,093,395 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Series F Redeemable Convertible Preferred Stock
2022-04-10$0.80/sh+1,740→ 1,740 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Series G Redeemable Preferred Stock
2022-04-10+3,260→ 3,260 total
Sale
NAVIDEA BIOPHARMACEUTICALS, INC.
Series E Redeemable Convertible Preferred Stock
2022-04-10$2.30/sh−50,000→ 0 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-03-31+2,500→ 8,090,895 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-02-28+2,500→ 8,088,395 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2022-01-31+2,500→ 8,085,895 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2021-12-31+2,500→ 8,083,395 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2021-11-30+1,250→ 8,080,895 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2021-11-15$0.00/sh+30,000→ 8,077,162 total
Award
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2021-11-15+2,483→ 8,079,645 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Series E Redeemable Convertible Preferred Stock
2021-03-02$100.00/sh+50,000→ 50,000 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2020-08-30$5.00/sh+5,000→ 8,047,162 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2020-02-13$0.85/sh+2,373,529→ 8,042,162 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2019-12-06$0.90/sh+555,555→ 5,668,633 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2019-06-18$0.75/sh+4,000,000→ 5,113,078 total
Purchase
NAVIDEA BIOPHARMACEUTICALS, INC.
Common Stock
2019-03-22$0.14/sh+357,143→ 22,261,565 total

Companies

NAVIDEA BIOPHARMACEUTICALS, INC.
10% Owner

Recent Filings

Address

5251 DTC PARKWAY, SUITE 285

GREENWOOD VILLAGE, CO, 80111

View on SEC.gov